(2007). Lyrica, Botox, Aricept & Hycamtin Case Study: The Benefits of New Drug Application Extensions. Marketline.
Cita Chicago Style (17a ed.)Lyrica, Botox, Aricept & Hycamtin Case Study: The Benefits of New Drug Application Extensions. Marketline, 2007.
Cita MLA (8a ed.)Lyrica, Botox, Aricept & Hycamtin Case Study: The Benefits of New Drug Application Extensions. Marketline, 2007.
Precaución: Estas citas no son 100% exactas.